Skip to content

How effective and safe is microneedling for acne scars?

Efficacy and safety of microneedling in the management of atrophic acne scars - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077601
Enrollment
30
Registered
2024-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L70- Acne

Interventions

Intervention1: Microneedling: Microneedling using handheld dermaroller device for atrophic acne scars will be done at 4 weekly intervals Control Intervention1: NA: NA

Sponsors

Institute of Medical Science, Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients aged between 18- 40 years with atrophic acne scars voluntarily seeking treatment at I.M.S., B.H.U., Varanasi 2. Absence of active lesions of acne while on or off treatment. 3. Informed consent

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Active lesions on treatment 3. Keloidal tendencies 4. Collagen vascular diseases 5. Bleeding disorders 6. Anticoagulant treatment 7. Active bacterial, fungal or viral infection over face 8. Any invasive acne scar treatment performed in the last 3 months. 9. History of photosensitivity 10. History of intake of oral isotretinoin, oral corticosteroids in the preceding 3 months 11. History of use of topical corticosteroids in the preceding 2 weeks

Design outcomes

Primary

MeasureTime frame
Qualitative Goodman Baron scores, Quantitative Goodman Baron scores, % improvement by patient assessmentTimepoint: baseline, 2 weeks, 6 weeks, 10 weeks, 14 weeks, 18 weeks

Secondary

MeasureTime frame
adverse effectsTimepoint: baseline, 2 weeks, 6 weeks, 10 weeks, 14 weeks, 18 weeks

Countries

India

Contacts

Public ContactTulika Rai

Institute of Medical Sciences, Banaras Hindu University

raitulika1323@gmail.com09962526261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026